Publication Beamlines Strategic Pillar
S·J·塞奥内; F·J·阿尼多; R·M·哈勒; P·E·拜利斯; A·耶加纳桑 et al. (2021). Methods for improving response to anti-LIF antibody therapy in individuals with cancer. Patent Number: CN112703202A.
Stephen G. Withers; Peter Rahfeld; Jayachandran Kizhakkedathu (2021). enzymatic compositions for carbohydrate antigen cleavage, methods, uses, apparatus and systems associated therewith. Patent Number: BR112021002899A2.
Stephen G. Withers; Peter Rahfeld; Jayachandran Kizhakkedathu (2021). Enzymatic compositions for carbohydrate antigen cleavage, methods, uses, apparatuses and systems associated therewith. Patent Number: US20210324361A1.
Suarez Joan Seoane; Folgueira Judit Anido; Robin Hallett; Patricia Giblin; Jeanne Magram et al. (2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: SG11202012576QA.
Suarez Joan Seoane; Folgueira Judit Anido; Robin Hallett; Peter Bayliss; Ajitha Jeganathan et al. (2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: SG11202012619WA.
Thomas SPRETER VON KREUDENSTEIN; Surjit Bhimarao Dixit; Eric Escobar-Cabrera; David Kai Yuen Poon; Paula Irene Lario et al. (2021). Stable heterodimeric antibody design with mutations in the fc domain. Patent Number: EP2773671B1.
Thomas SPRETER VON KREUDENSTEIN; Surjit Bhimarao Dixit; Eric Escobar Cabrera; Paula I. Lario; David Kai Yuen Poon et al. (2021). isolated heteromultimeric fc construct, composition, use of an isolated heteromultimeric fc construct, nucleic acid composition and method for expressing the isolated heteromultimeric fc construct. Patent Number: BR112014010580B1.
Trushar R. PATEL; Carla Stephanie COFFIN; Vanessa MEIER-STEPHENSON; Maulik D. BADMALIA (2021). Polypeptides directed against viral infection and uses thereof. Patent Number: CA3169031A1.
Trushar R. PATEL; Carla Stephanie COFFIN; Vanessa MEIER-STEPHENSON; Maulik D. BADMALIA (2021). Polypeptides directed against viral infection and uses thereof. Patent Number: WO2021168575A1.
Venu Varanasi; Pranesh Aswath; Megen Maginot; Nickolay V. Lavrick (2021). Amorphous silicon oxide, amorphous silicon oxynitride, and amorphous silicon nitride thin films and uses thereof. Patent Number: US10898618B2. SGM, VLS-PGM Materials
Von Kreudenstein Thomas Spreter; Surjit Bhimarao Dixit; Eric Escobar-Cabrera; David Kai Yuen Poon; Paula Irene Lario et al. (2021). DESIGN OF STABLE HETERODIMED ANTIBODY WITH MUTATIONS IN THE FC DOMAIN. Patent Number: DK2773671T3.
Von Kreudenstein Thomas Spreter; Surjit Bhimarao Dixit; Eric Escobar-Cabrera; David Kai Yuen Poon; Paula Irene Lario et al. (2021). Stable heterodimeric antibody design with mutations in the fc domain. Patent Number: RS62689B1.
Xin Chen; Nicolas Baurin; Dorothea KOMINOS; Jie Zhang; Alla Pritsker et al. (2021). Antibodies to bradykinin b1 receptor ligands.. Patent Number: MX2018015914A.
Жоан Сеоане Суарез; Джудит Анидо Фолгуэйра; Йохан Франссон; Робин Мэттью Халлетт; Моника Паскуаль Гарсиа et al. (2021). COMBINATION OF LIF INHIBITORS AND PD-1 AXIS INHIBITORS FOR USE IN THE TREATMENT OF CANCER. Patent Number: EA202092360A1.
Жоан Сеоане Суарез; Джудит Анидо Фолгуэйра; Робин Мэттью Халлетт; Патрисиа Энн Гиблин; Жанн Маграм et al. (2021). COMBINATION OF LIF INHIBITORS AND ANTINEOPLASTIC AGENTS ON THE BASIS OF PLATINUM FOR USE IN THE TREATMENT OF CANCER. Patent Number: EA202092964A1.